Dr. Arndt Schottelius, CEO of Maxion Therapeutics, is a physician-scientist with a standout career across Genentech, MorphoSys, Kymab, and now at one of the UK’s most promising biotech companies. At Maxion, he leads a team pioneering KnotBody technology - an innovative approach to targeting ion channels and GPCRs, long considered “undruggable” with biologics. Arndt brings more than 25 years of experience across translational science, drug development and leadership in global R&D. His conviction, clarity, and track record - including developing molecules that have become partnered, acquired and approved - makes this conversation a must-listen for anyone in life sciences leadership.

In this episode, we cover:

• How Maxion is building a new therapeutic modality using KnotBody technology to tackle autoimmune and inflammatory diseases
• Why conviction, speed, and storytelling are non-negotiable in translational drug development
• Lessons from Genentech, MorphoSys, and Kymab on building pipelines, teams, and partnerships
• What investors really look for - and how Maxion secured a competitive Series A in a tough market
• How to hire and scale for scientific excellence without losing agility or collaboration

Tune in for a dynamic, insightful conversation with one of biotech’s most experienced and thoughtful leaders.

Follow ARTO

LinkedIn: https://www.linkedin.com/company/artotalent

Spotify: Leading Beyond The Lab

Instagram: Instagram (@arto.talent)

TikTok: artotalent on TikTok

Apple Podcasts: Leading Beyond The Lab

Website: Home

Youtube: ARTO Recruitment

Arndt Schottelius

CEO at Maxion Theraprutics

LinkedIn: https://www.linkedin.com/in/arndt-schottelius-md-ph/

Lawrence Rose

Co-Founder + Talent Solutions Director At ARTO

LinkedIn: https://www.linkedin.com/in/lawrencerose/

Timestamps:

00:00 Career Beginnings

06:46 Translational Science

08:55 Lessons in Biotech Leadership

25:23 Maxion - Culture and Roundup

#LeadingBeyondTheLab #ARTOTalent #Biotechnology 

Hosted on Acast. See acast.com/privacy for more information.